Home > News
|
Clinical Trials Update: Jan. 6, 2004 |
|
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Amyotrophic Lateral Sclerosis (ALS)
A research study to test the safety, tolerability, and effectiveness of an investigational medication in patients with amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease). Volunteers 21 to 80 who have a confirmed diagnosis of ALS may be eligible. Research site located in Kansas City, Kan.
More Information
Please see http://www.centerwatch.com/patient/studies/cat160.html.
-----
Mantle Cell Lymphoma
A research study of an investigational medication for Mantle Cell Lymphoma. Volunteers at least 18 or older who have documented relapsed or refractory Mantle Cell Lymphoma following at least 1 or more prior therapies and who have adequate organ function may be eligible. Research site located in Iowa City, Iowa.
More Information
Please see http://www.centerwatch.com/patient/studies/cat628.html.
-----
Anemia
An experimental study for treating anemia in cancer subjects. Volunteers 18 or older who have anemia resulting from cancer, chemotherapy, or radiotherapy, who are stable for 1 month before the study starts and have a life expectancy of 9 months or greater based on the judgment of the investigator may be eligible. Research site located in Jamaica, NY.
More Information
Please see http://www.centerwatch.com/patient/studies/cat373.html.
-----
Copyright 2004 CenterWatch. All rights reserved.
Copyright © 2004 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library.
